create a website

Investor Sentiment, Innovation Investment and Cash Dividend. (2019). Xu, Xiaoyang ; Hao, Lizhong ; Wang, Dandan ; Isaac, Adubofour.
In: International Journal of Economics and Finance.
RePEc:ibn:ijefaa:v:11:y:2019:i:7:p:97.

Full description at Econpapers || Download paper

Cited: 2

Citations received by this document

Cites: 19

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Stock Mispricing and Firm Innovation: Evidence from an Emerging Equity Market. (2024). Duong, Le Quy.
    In: SN Operations Research Forum.
    RePEc:spr:snopef:v:5:y:2024:i:4:d:10.1007_s43069-024-00394-w.

    Full description at Econpapers || Download paper

  2. Do foreign acquisitions improve target firms’ green innovation performance?. (2024). Chen, Yuhuilin ; Guo, Xinran ; Ni, Tao ; Yuan, Ruizhi.
    In: International Review of Economics & Finance.
    RePEc:eee:reveco:v:95:y:2024:i:c:s1059056024004507.

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Am. Econ. Rev., 98(2), 451-456. https://doi.org/10.1257/aer.98.2.451 Aw, B. Y., Roberts, M. J., & Xu, D. Y. (2011). R&D investment, exporting, and productivity dynamics. Am. Econ.
    Paper not yet in RePEc: Add citation now
  2. Amid, A., Moalagh, M., & Zare, R. A. (2012). Identification and classification of ERP critical failure factors in Iranian industries. Inf. Syst., 37(3), 227-237. https://doi.org/10.1016/j.is.2011.10.010 Aula, P. (2010). Social media, reputation risk and ambient publicity management. Strategy Leadership, 38(6), 43-49. https://doi.org/10.1108/10878571011088069 Avison, D., Jones, J., Powell, P., & Wilson, D. (2004). Using and validating the strategic alignment model. J.
    Paper not yet in RePEc: Add citation now
  3. Black, F. (1976). The dividend puzzle. Journal of Portfolio Management, 2, 5-8.
    Paper not yet in RePEc: Add citation now
  4. Commun., 18(1), 97-112. https://doi.org/10.1111/j.1083-6101.2012.01595.x Wenping, Z., Lele, K., Qiqi, J., & Lei, P. (2018). From buzz to bucks: The impact of social media opinions on the locus of innovation. Journal of Electronic Commence and Applications, (30), 125-137. https://doi.org/10.1016/j.elerap.2018.04.004 Wenzhao, W. (2018). Investor sentiment and the mean-variance relationship: European evidence. Research in International Business and Finance. https://doi.org/10.1016/j.ribaf.2018.02.006 Wooldridge, J. M. (2010). Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press.
    Paper not yet in RePEc: Add citation now

  5. Derks, D., Fischer, A. H., & Bos, A. E. R. (2008). The role of emotion in computer-mediated communication: A review. Comput. Hum. Behav., 24(3), 766-785. https://doi.org/10.1016/j.chb.2007.04.004 DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003). The price of innovation: new estimates of drug development costs. J. Health Econ., 22(2). https://doi.org/10.1016/S0167-6296(02)00126-1 Feldstein, M., & Green, J. (1983). Why do companies pay dividends? American Economic Review, 73, 7-30.

  6. Hall, B. H., & Lerner, J. (2010). The Financing of R&D and Innovation. In B. H. Hall, & N. Rosenber (Eds.), Handbook of Economics and Innovation. Elsevier-North Holland.

  7. https://doi.org/10.1016/0304-405X(78)90009-0 Morck, R. A. S., & Vishny, R. (1990). The stock market and investment: is the market a sideshow? Brookings Papers on Economic Activity, 157-202. https://doi.org/10.2307/2534506 Morgan, R. E., & Berthon, P. (2008). Market orientation, generative learning, innovation strategy and business performance inter-relationships in bioscience firms. J. Manage. Stud., 45(8), 1329-1353. https://doi.org/10.1111/j.1467-6486.2008.00778.x Mujtaba, G. M., Piyush, S., & Ferdinand, A. G. (2018). Investor sentiment and advertising expenditure.

  8. https://doi.org/10.1016/S0169-7218(10)01014-2 He, W., Zha, S., & Li, L. (2013). Social media competitive analysis and text mining: A case study in the pizza industry. Int. J. Inf. Manage., 33(3), 464-472. https://doi.org/10.1016/j.ijinfomgt.2013.01.001 Hua, G. R., Liu, Z. Y., & Xu, Q. (2011). Investor Sentiment, Managerial Optimism and Corporate Investment. Journal of Financial Research, 9, 178-191.
    Paper not yet in RePEc: Add citation now

  9. https://doi.org/10.1016/S1062-9769(02)00151-5 Baker, M., & Wurgler, J. (2007). Investor Sentiment in the Stock Market. Journal of Economic Perspectives, 21, 129-151. https://doi.org/10.1257/jep.21.2.129 Baumeister, R. F., Bratslavsky, E., Finkenauer, C., & Vohs, K. D. (2001). Bad Is stronger than good. Rev. Gen.

  10. ijef.ccsenet.org International Journal of Economics and Finance Vol. 11, No. 7; 2019 https://doi.org/10.1016/j.intmar.2013.09.008 Miller, M. H., & Shiller, R. J. (1986). Behavioral rationality in finance: The case of dividends. Journal of Business, 59, S451-S468. https://doi.org/10.1086/296380 Miller, M., & Modigliani, F. (1961). Dividend policy, growth, and the valuation of shares. Journal of Business, 34, 411-433. https://doi.org/10.1086/294442 Miller, M., & Scholes, M. (1978). Dividends & taxes. Journal of Financial Economics, 6, 333-364.
    Paper not yet in RePEc: Add citation now
  11. Inf. Manage., 41(8), 1003-1020. https://doi.org/10.1016/j.im.2003.10.004 Bessant, J. et al. (2005). Enabling continuous and discontinuous innovations: Some reflections from a private sector perspective. Public Money and Management, 25(1).
    Paper not yet in RePEc: Add citation now

  12. International Journal of Research In Marketing. https://doi.org/10.1016/j.ijresmar.2018.08.005 Perez, C. (2002). Technological Revolutions and Financial Capital. Edward Elgar. https://doi.org/10.4337/9781781005323 Shiller, B. (2000). Irrational Exuberance. Princeton, NJ: Princeton University Press.

  13. Liu, Y., Chen, Y., Lusch, R., Chen, H., Zimbra, D., & Zeng, S. (2010). User-generated content on social media: predicting market success with online word-of-mouth. IEEE Intell Syst., 25(1), 75-78.
    Paper not yet in RePEc: Add citation now

  14. Malthouse, E. C., Haenlein, M., Skiera, B., Wege, E., & Zhang, M. (2013). Managing customer relationships in the social media era: introducing the Social CRM House. J. Interact. Market, 27(4), 270-280.

  15. Psychol., 5(4), 323-370. https://doi.org/10.1037/1089-2680.5.4.323 Belderbos, R., Carree, M., & Lokshin, B. (2004). Cooperative R&D and firm performance. Res. Policy, 33(10), 1477-1492. https://doi.org/10.1016/j.respol.2004.07.003 Berchicci, L. (2013). Towards an open R&D system: Internal R&D investment, external knowledge acquisition and innovative performance. Res. Policy, 42(1), 117-127. https://doi.org/10.1016/j.respol.2012.04.017 Bergeron, F., Raymond, L., & Rivard, S. (2004). Ideal patterns of strategic alignment and business performance.

  16. Rev., 101(4), 1312-1344. https://doi.org/10.1257/aer.101.4.1312 Baker, H. K., Powell, G. E., & Veit, E. T. (2002). Why companies use open-market repurchases: A managerial perspective. Quarterly Review of Economics and Finance, (in press).

  17. Solow, R. (1957). Technical Change and the Aggregate Production Function. Review of Economics and Statistics, 39, 312-320. https://doi.org/10.2307/1926047 Tanya, A., Samuel, E., & Francisco, L. (2018). Do sentiments influence market dynamics? A reconstruction of the Brazilian stock market and its mood. https://doi.org/10.1016/j.physa.2018.04.045 Tri, V. D., & Zhaoxia, X. (2016). Market sentiment and innovation activities. Tsinghua University press.
    Paper not yet in RePEc: Add citation now

  18. Strategic Inf. Syst., 13(3), 223-246. https://doi.org/10.1016/j.jsis.2004.08.002 Aw, B. Y., Roberts, M. J., & Xu, D. Y. (2008). R&D Investments, Exporting, the evolution of firm productivity.

  19. Walther, J. B., Liang, Y., Ganster, T., Wohn, D. Y., & Emington, J. (2012). Online reviews, helpfulness ratings, and consumer attitudes: An extension of congruity theory to multiple sources in Web 2.0. J. Comput.-Med.
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry. (2014). Siebert, Ralph ; Banerjee, Tannista.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_4567.

    Full description at Econpapers || Download paper

  2. Eliminating the U.S. drug lag: Implications for drug safety. (2013). Olson, Mary.
    In: Journal of Risk and Uncertainty.
    RePEc:kap:jrisku:v:47:y:2013:i:1:p:1-30.

    Full description at Econpapers || Download paper

  3. Understanding a firms openness decisions in innovation. (2012). Drechsler, Wenzel ; Natter, Martin.
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:65:y:2012:i:3:p:438-445.

    Full description at Econpapers || Download paper

  4. The efficiency and stability of R&D networks. (2012). Schweitzer, Frank ; Napoletano, Mauro ; König, Michael ; battiston, stefano ; Knig, Michael D..
    In: Games and Economic Behavior.
    RePEc:eee:gamebe:v:75:y:2012:i:2:p:694-713.

    Full description at Econpapers || Download paper

  5. An Economic Evaluation of the War on Cancer. (2009). Sun, Eric ; Philipson, Tomas ; Lakdawalla, Darius ; Jena, Anupam ; Goldman, Dana ; Reyes, Carolina M..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15574.

    Full description at Econpapers || Download paper

  6. Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation?. (2009). Grootendorst, Paul.
    In: Social and Economic Dimensions of an Aging Population Research Papers.
    RePEc:mcm:sedapp:250.

    Full description at Econpapers || Download paper

  7. Trials, Tricks and Transparency: How Disclosure Rules Affect Clinical Knowledge. (2008). González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Working Papers.
    RePEc:pab:wpaper:08.02.

    Full description at Econpapers || Download paper

  8. What is a Company Really Worth? Intangible Capital and the Market to Book Value Puzzle. (2008). Hao, Xiaohui ; Hulten, Charles R..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14548.

    Full description at Econpapers || Download paper

  9. Effects of Regulation on Drug Launch and Pricing in Interdependent Markets. (2008). Danzon, Patricia ; Epstein, Andrew J..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14041.

    Full description at Econpapers || Download paper

  10. On international cost-sharing of pharmaceutical R&D. (2008). Martinez-Giralt, Xavier ; Barros, Pedro.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:8:y:2008:i:4:p:301-312.

    Full description at Econpapers || Download paper

  11. Firm boundary decisions: the market for health-related R&D services with an empirical case study for Germany. (2008). Baumann, Oliver ; Grupp, Hariolf.
    In: International Economics and Economic Policy.
    RePEc:kap:iecepo:v:5:y:2008:i:3:p:297-321.

    Full description at Econpapers || Download paper

  12. Financial Analysts impact on Stock Volatility. A Study on the Pharmaceutical Sector. (2008). Gonzalez, Clara ; Gimeno, Ricardo.
    In: Working Papers.
    RePEc:fda:fdaddt:2008-19.

    Full description at Econpapers || Download paper

  13. The Benefits and Savings of Publicly-Funded Clinical Trials of Prescription Drugs. (2008). Baker, Dean.
    In: CEPR Reports and Issue Briefs.
    RePEc:epo:papers:2008-09.

    Full description at Econpapers || Download paper

  14. A model of parallel imports of pharmaceuticals with endogenous price controls. (2008). Sauer, Katherine .
    In: Economics Bulletin.
    RePEc:ebl:ecbull:v:6:y:2008:i:36:p:1-8.

    Full description at Econpapers || Download paper

  15. Is the Food And Drug Administration Safe And Effective?. (2008). Sun, Eric ; Philipson, Tomas.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:22:y:2008:i:1:p:85-102.

    Full description at Econpapers || Download paper

  16. Generic competition and market exclusivity periods in pharmaceuticals. (2007). Kyle, Margaret ; Grabowski, Henry G..
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:491-502.

    Full description at Econpapers || Download paper

  17. The cost of biopharmaceutical R&D: is biotech different?. (2007). DiMasi, Joseph ; Grabowski, Henry G..
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:469-479.

    Full description at Econpapers || Download paper

  18. Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry. (2007). Masia, Neal ; Filson, Darren.
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:329-351.

    Full description at Econpapers || Download paper

  19. The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions. (2007). Abbott, Thomas A. ; Vernon, John A..
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:293-306.

    Full description at Econpapers || Download paper

  20. If it aint broke, dont price fix it: the OFT and the PPRS. (2007). Towse, Adrian.
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:7:p:653-665.

    Full description at Econpapers || Download paper

  21. A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development. (2007). Pammolli, Fabio ; Magazzini, Laura ; Arora, Ashish ; Gambardella, Alfonso.
    In: MPRA Paper.
    RePEc:pra:mprapa:16042.

    Full description at Econpapers || Download paper

  22. The Welfare Effects of Public Drug Insurance. (2007). Sood, Neeraj ; Lakdawalla, Darius.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13501.

    Full description at Econpapers || Download paper

  23. International Comparisons of R&D Expenditure: Does an R&D PPP Make a Difference?. (2007). van Ark, Bart ; Inklaar, Robert ; Dougherty, Sean ; McGuckin, Robert H..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12829.

    Full description at Econpapers || Download paper

  24. The Effect of Advertising on Pharmaceutical Innovation. (2007). Norton, Edward ; Kwong, Winghan.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:31:y:2007:i:3:p:221-236.

    Full description at Econpapers || Download paper

  25. Is it possible to have cheaper drugs and preserve the incentive to innovate? The benefits of privatizing the drug approval process. (2007). Sauer, Robert.
    In: The Journal of Technology Transfer.
    RePEc:kap:jtecht:v:32:y:2007:i:5:p:509-524.

    Full description at Econpapers || Download paper

  26. Merck and Vioxx: An Examination of an Ethical Decision-Making Model. (2007). Cavusgil, Erin.
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:76:y:2007:i:4:p:451-461.

    Full description at Econpapers || Download paper

  27. Pharmaceutical Innovation. (2007). Scherer, F. M..
    In: Working Paper Series.
    RePEc:ecl:harjfk:rwp07-004.

    Full description at Econpapers || Download paper

  28. Pharmaceutical promotion and GP prescription behaviour. (2006). Windmeijer, Frank ; Douven, Rudy ; Mot, Esther ; de Laat, Eric.
    In: Health Economics.
    RePEc:wly:hlthec:v:15:y:2006:i:1:p:5-18.

    Full description at Econpapers || Download paper

  29. Can€™t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations. (2006). Häussler, Carolin ; Haussler, Carolin.
    In: Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems.
    RePEc:trf:wpaper:189.

    Full description at Econpapers || Download paper

  30. Cluster Performance reconsidered: Structure, Linkages and Paths in the German Biotechnology Industry, 1996-2003. (2006). Häussler, Carolin ; Zademach, Hans-Martin ; Haussler, Carolin.
    In: Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems.
    RePEc:trf:wpaper:188.

    Full description at Econpapers || Download paper

  31. European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending. (2006). Golec, Joseph H. ; Vernon, John A..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12676.

    Full description at Econpapers || Download paper

  32. Innovation, Competition and Welfare-Enhancing Monopoly. (2006). Zucker, Lynne ; Darby, Michael.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12094.

    Full description at Econpapers || Download paper

  33. Innovation and market dynamics in the EPO market. (2006). Strøm, Steinar ; Sorisio, Enrico.
    In: Memorandum.
    RePEc:hhs:osloec:2006_012.

    Full description at Econpapers || Download paper

  34. The Conservative Nanny State. (2006). Baker, Dean.
    In: CEPR Books.
    RePEc:epo:booksx:2006-01.

    Full description at Econpapers || Download paper

  35. Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry. (2005). Heneric, Oliver ; Fier, Andreas.
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:4543.

    Full description at Econpapers || Download paper

  36. Examining the link between price regulation and pharmaceutical R&D investment. (2005). Vernon, John A..
    In: Health Economics.
    RePEc:wly:hlthec:v:14:y:2005:i:1:p:1-16.

    Full description at Econpapers || Download paper

  37. The contribution of skilled immigration and international graduate students to U.S. innovation. (2005). Mattoo, Aaditya ; Maskus, Keith ; Chellaraj, Gnanaraj.
    In: Policy Research Working Paper Series.
    RePEc:wbk:wbrwps:3588.

    Full description at Econpapers || Download paper

  38. A General-Equilibrium Analysis of Public Policy for Pharmaceutical Prices. (2005). Rebelein, Robert ; Kelton, Christina M. L., .
    In: Vassar College Department of Economics Working Paper Series.
    RePEc:vas:papers:78.

    Full description at Econpapers || Download paper

  39. Production of a New Drug: A Sequential Investment ProcessUnder Uncertainty. (2005). Zappia, Carlo ; Renò, Roberto ; Basili, Marcello ; Reno, Roberto.
    In: Department of Economics University of Siena.
    RePEc:usi:wpaper:453.

    Full description at Econpapers || Download paper

  40. Initiatives on a Sustainable Development Strategy for Finnish Biotechnology. (2005). Hermans, Raine ; Kulvik, Martti.
    In: Discussion Papers.
    RePEc:rif:dpaper:988.

    Full description at Econpapers || Download paper

  41. The Future of Drug Development: The Economics of Pharmacogenomics. (2005). Hughen, Keener W. ; Vernon, John A..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11875.

    Full description at Econpapers || Download paper

  42. The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions. (2005). Abbott, Thomas A. ; Vernon, John A..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11114.

    Full description at Econpapers || Download paper

  43. Pharmaceutical Knowledge-Capital Accumulation and Longevity. (2005). Lichtenberg, Frank R..
    In: NBER Chapters.
    RePEc:nbr:nberch:10623.

    Full description at Econpapers || Download paper

  44. Reconciling social and industrial goals: a bargaining model to pricing pharmaceuticals. (2005). LEVAGGI, ROSELLA ; Capri, Stefano.
    In: LIUC Papers in Economics.
    RePEc:liu:liucec:170.

    Full description at Econpapers || Download paper

  45. Market Structure and Drug Innovation. (2004). Riccaboni, Massimo ; Pammolli, Fabio.
    In: MPRA Paper.
    RePEc:pra:mprapa:16212.

    Full description at Econpapers || Download paper

  46. Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms. (2004). Scharfstein, David ; Guedj, Ilan.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:10933.

    Full description at Econpapers || Download paper

  47. To reach the poor: Results from the ISNAR-IFPRI Next Harvest study on genetically modified crops, public research, and policy implications. (2004). Zambrano, Patricia ; Smale, Melinda ; Falck Zepeda, José ; Sutrisno,, ; Cohen, Joel I. ; Sampaio,, ; Idah Sithole-Niang, Maria Jose, ; Valyasevi, Ruud ; Ebora, Reynaldo V. ; Quemada, Hector ; Low, Fee Chon ; Omaliko, Emeka ; Burachik, Moises ; Odhiambo, Benjamin ; Herrera-Estrella, Luis ; Atanassov, Atanas ; Zafar, Yusuf ; Falck-Zepeda, Jose ; Sittenfeld, Ana ; Peng, Yufa ; Komen, John ; Bahieldin, Ahmed ; Dhawan, Vibha ; Brink, Johan .
    In: EPTD discussion papers.
    RePEc:fpr:eptddp:116.

    Full description at Econpapers || Download paper

  48. Valuation of a Biotech Company: A Real Options Approach. (2004). Pieiro, Diego ; Leon, Angel.
    In: Working Papers.
    RePEc:cmf:wpaper:wp2004_0420.

    Full description at Econpapers || Download paper

  49. Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances. (2003). Sousa Pereira, Nuno ; Nicholson, Sean ; Danzon, Patricia.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:9615.

    Full description at Econpapers || Download paper

  50. Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry. (2003). Linn, Joshua ; Acemoglu, Daron.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:10038.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-09-20 22:44:10 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated August, 3 2024. Contact: Jose Manuel Barrueco.